Use of Cefiderocol in the Management of Children With Infection or Colonization With Multi-drug Resistant Gram-negative Bacteria: A Retrospective, Single-center Case Series.
Pediatr Infect Dis J
; 43(8): 772-776, 2024 Aug 01.
Article
de En
| MEDLINE
| ID: mdl-38564757
ABSTRACT
Cefiderocol, a novel siderophore cephalosporin, represents a treatment option for infections with multidrug-resistant Gram-negative bacteria, of which rates are rising worldwide. Clinical data on its use in children is limited. In our pediatric case series, the largest reported to date, cefiderocol seems safe and well tolerated, with more favorable clinical outcomes when compared to the literature reviewing adult cases.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Céphalosporines
/
Infections bactériennes à Gram négatif
/
Multirésistance bactérienne aux médicaments
/
/
Bactéries à Gram négatif
/
Antibactériens
Limites:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Langue:
En
Journal:
Pediatr Infect Dis J
Sujet du journal:
DOENCAS TRANSMISSIVEIS
/
PEDIATRIA
Année:
2024
Type de document:
Article